Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study

Abstract

ObjectivesThe epidemiology of post-COVID syndrome (PCS) is currently undefined. We quantified rates of organ-specific impairment following recovery from COVID-19 hospitalisation compared with those in a matched control group, and how the rate ratio (RR) varies by age, sex, and ethnicity.DesignObservational, retrospective, matched cohort study.SettingNHS hospitals in England.Participants47,780 individuals (mean age 65 years, 55% male) in hospital with COVID-19 and discharged alive by 31 August 2020, matched to controls on demographic and clinical characteristics.Outcome measuresRates of hospital readmission, all-cause mortality, and diagnoses of respiratory, cardiovascular, metabolic, kidney and liver diseases until 30 September 2020.ResultsMean follow-up time was 140 days for COVID-19 cases and 153 days for controls. 766 (95% confidence interval: 753 to 779) readmissions and 320 (312 to 328) deaths per 1,000 person-years were observed in COVID-19 cases, 3.5 (3.4 to 3.6) and 7.7 (7.2 to 8.3) times greater, respectively, than in controls. Rates of respiratory, diabetes and cardiovascular events were also significantly elevated in COVID-19 cases, at 770 (758 to 783), 127 (122 to 132) and 126 (121 to 131) events per 1,000 person-years, respectively. RRs were greater for individuals aged <70 than ≥ 70 years, and in ethnic minority groups than the White population, with the biggest differences observed for respiratory disease: 10.5 [9.7 to 11.4] for <70 years versus 4.6 [4.3 to 4.8] for ≥ 70 years, and 11.4 (9.8 to 13.3) for Non-White versus 5.2 (5.0 to 5.5) for White.ConclusionsIndividuals discharged from hospital following COVID-19 face elevated rates of multi-organ dysfunction compared with background levels, and the increase in risk is neither confined to the elderly nor uniform across ethnicities. The diagnosis, treatment and prevention of PCS require integrated rather than organ- or disease-specific approaches. Urgent research is required to establish risk factors for PCS.

David Oliver: Mistruths and misunderstandings about covid-19 death numbers

“…We sometimes certify deaths in patients who died from covid-19 or its complications well beyond 28 days. A study from Leicester University followed over 40 000 people with covid-19 discharged from hospital for 140 days and found a readmission rate of 31% (23% within 60 days), with 9% dying on readmission 10. Obviously not all those deaths were from covid complications, but it seems clear that many were accelerated by them.…”

Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform

“…A recent observational study measured similar outcome events in a population of patients discharged from hospital following COVID-19 11 . They observed elevated rates in the COVID-19 population compared to a matched general population control group.…”

Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients During the COVID-19 Pandemic

“…In addition, it is reported that 12.3% of individuals in hospital with COVID-19 died within 140 days following discharge, which indicated that recovered individuals from COVID-19 face higher mortality compared with the background levels [13].…”